Institution
University of California, Los Angeles
Also known as: State Normal School at Los Angeles · UC Los Angeles · Universidad de California en Los Ángeles · University of California Southern Branch · University of California at Los Angeles · Université de Californie à Los Angeles
- 238running trials
- 112closed trials
- 507,022publications (OpenAlex)
Running trials
Recruiting
IMAGES: Identifying Metabolic Imaging Association With Genicular Artery Embolization Success
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Pre-emptive RTO for An Early Detected Gastric Varices in CT/MR Angiogram Trial
Recruiting
Not yet recruiting
Not yet recruiting
Adalimumab Dose Adjustment for Pediatric Uveitis Treatment Trial
Not yet recruiting
Screening For Social Determinants Of Health In Routine Diabetes Care
Not yet recruiting
Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Recruiting
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Recruiting
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Recruiting
Health And Response: Digital Markers for Outcomes in Perinatal Depression Treatment Study
Recruiting
Recruiting
Recruiting
Recruiting
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
Recruiting
Sleep Learning Education and Empowerment for Older Korean Immigrants
Recruiting
Active, not recruiting
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Enrolling by invitation
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Enrolling by invitation
Understanding Freezing of Gait Using Brain Signals and Virtual Reality
Recruiting
New T-UP: Engaging Vulnerable Students in Diabetes Prevention
Recruiting
Recruiting
Recruiting
Recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Recruiting
Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
Recruiting
Recruiting
Recruiting
Recruiting
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Showing 50 of 238.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer8 recruiting
- Childhood cancers7 recruiting
- Parkinson disease7 recruiting
- Colorectal cancer6 recruiting
- Lung cancer6 recruiting
- Alzheimer disease5 recruiting
- Pancreatic cancer5 recruiting
- Gastric and oesophageal cancer4 recruiting
- Glioblastoma4 recruiting
- Head and neck cancer4 recruiting
- Metastatic breast cancer4 recruiting
- Schizophrenia4 recruiting
- Type 2 diabetes4 recruiting
- Acute myeloid leukaemia3 recruiting
- COPD3 recruiting
- Endometrial cancer3 recruiting
- Epilepsy3 recruiting
- Gestational diabetes3 recruiting
- Melanoma3 recruiting
- Stroke3 recruiting
- Type 1 diabetes3 recruiting
- ALS (motor neurone disease)2 recruiting
- Autism2 recruiting
- Bladder cancer2 recruiting
- Congenital heart disease2 recruiting
- Cystic fibrosis2 recruiting
- Duchenne muscular dystrophy2 recruiting
- Frontotemporal dementia2 recruiting
- Heart failure2 recruiting
- High blood pressure2 recruiting
- Irritable bowel syndrome2 recruiting
- Lewy body dementia2 recruiting
- Lupus (SLE)2 recruiting
- Mild cognitive impairment2 recruiting
- Multiple system atrophy2 recruiting
- Myelodysplastic syndromes2 recruiting
- Myotonic dystrophy2 recruiting
- Neuroendocrine tumours2 recruiting
- Osteoarthritis2 recruiting
- Ovarian cancer2 recruiting
- Pulmonary arterial hypertension2 recruiting
- Sarcoma2 recruiting
- Sickle cell disease2 recruiting
- Spinal cord injury2 recruiting
- Vascular dementia2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Aortic aneurysm1 recruiting
- Aortic stenosis1 recruiting
- Aplastic anaemia1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Barrett's oesophagus1 recruiting
- Brain metastases1 recruiting
- Cervical cancer1 recruiting
- Coronary artery disease1 recruiting
- Crohn's disease1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Diabetic foot ulcer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometriosis1 recruiting
- Fabry disease1 recruiting
- Friedreich ataxia1 recruiting
- HIV1 recruiting
- Huntington's disease1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Insomnia1 recruiting
- Lichen planus1 recruiting
- Liver and biliary tract cancer1 recruiting
- Macular degeneration1 recruiting
- Mantle cell lymphoma1 recruiting
- Myocarditis1 recruiting
- Peripheral artery disease1 recruiting
- Rheumatoid arthritis1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Thalassaemia1 recruiting
- Triple-negative breast cancer1 recruiting
- Ulcerative colitis1 recruiting
- Uterine fibroids1 recruiting
- Ventricular tachycardia1 recruiting
Closed trials
Terminated
Recruiting
Completed
Terminated
Completed
Molecular Analysis for Precision Surgery in Thyroid Cancer Trial
Withdrawn
Completed
Completed
Completed
Completed
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Terminated
Completed
Completed
Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis
Withdrawn
Adaptation of the PCIP for Spanish Speaking Adolescents and Families
Withdrawn
Completed
Terminated
Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC
Withdrawn
Completed
Completed
Terminated
Terminated
Completed
Terminated
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Completed
Completed
Completed
Completed
Completed
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
Completed
Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients
Completed
Remote Assessment and Intervention for Behavior Problems in Kids With TSC
Terminated
Completed
LIFUP for Treatment of Motor Deficits in Parkinson's Disease
Completed
Recruiting
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Completed
Completed
Completed
A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors
Terminated
Terminated
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Completed
Terminated
Completed
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
Withdrawn
Completed
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir
Completed
Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma
Completed
Completed
Completed
Showing 50 of 112.
Registry name variants (40)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
University of California, Los Angeles
Los Angeles, California 90095
268 trials
University of California, Los Angeles
Santa Monica, California 90404
22 trials
University of California at Los Angeles
Los Angeles, California 90095-1406
20 trials
University of California Los Angeles
Torrance, California 90505
3 trials
Contact: Boehringer Ingelheim
NCT03594110EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
University of California, Los Angeles
Westwood, Los Angeles, California 90095
3 trials
University California, Los Angeles
Los Angeles, California 90404
2 trials
Contact: Monica Rocha
University of California Los Angeles - Division of Dermatology
Los Angeles, California 90024
2 trials
8400693 - University of California Los Angeles
Los Angeles, California 90038
1 trial
UC Los Angeles
Los Angeles, California 90095 - 7370
1 trial
NCT05641688[18F]PI-2620 Phase 3 Histopathological Study
Contact: Audrey Perrotin, PhD
University of California at Los Angeles
Santa Monica, California 90404
1 trial
NCT07529808Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Contact: Rachel Andes
University of California at Los Angeles
Torrance, California 90509-2004
1 trial
University of California Los Angeles
Alhambra, California 91801
1 trial
University of California Los Angeles
Sylmar, California 91342
1 trial
University of California Los Angeles - David Geffen School of Medicine - Westwood Rheumatology
Los Angeles, California 90095
1 trial
University of California Los Angeles Department of Medicine
Los Angeles, California 90095
1 trial
University of California Los Angeles Department of Radiation Oncology
Los Angeles, California 90095
1 trial
University of California Los Angeles, Department of Urology
Los Angeles, California 90095
1 trial
University of California, Los Angeles
Los Angeles, California 90095
1 trial
University of California, Los Angeles
Los Angeles, California 90095
1 trial
University of California, Los Angeles
Los Angeles, California 90095
1 trial
University of California, Los Angeles
Los Angeles, California 90095
1 trial
University of California, Los Angeles
Los Angeles, California 90095
1 trial
University of California, Los Angeles
Los Angeles, California 90095
1 trial
University of California, Los Angeles
Los Angeles, California 90095
1 trial
University of California, Los Angeles
Los Angeles, California 90095
1 trial
University of California, Los Angeles
Los Angeles, California 90095
1 trial
University of California, Los Angeles
Los Angeles, California 90095
1 trial
University of California, Los Angeles
Los Angeles, California 90095
1 trial
University of California Los Angeles
Los Angeles, California 90095
1 trial
University of California Los Angeles
Los Angeles, California 90095-3075
1 trial
University of California Los Angeles, Nuclear Medicine
Los Angeles, California 90095
1 trial
University of California, Los Angeles, Santa Monica Hematology/Oncology
Los Angeles, California 90095
1 trial
University of California, Los Angeles School of Medicine
Los Angeles, California 90095-3000
1 trial
University of California, Los Angeles, School of Medicine
Santa Monica, California 90404
1 trial
University of California, Los Angeles (Site #: 71123)
Los Angeles, California 90095
1 trial
Contact: Paul Lopez
University Of California Los Angeles- Site Number : 840088
Los Angeles, California 90095
1 trial
NCT00196742Fabry Disease Registry & Pregnancy Sub-registry
Contact: Trial Transparency
University of Los Angeles, California
Los Angeles, California 90095
1 trial
Univ. of California Los Angeles
Los Angeles, California 90095
1 trial
Univ of California @ Los Angeles (Site 325)
Los Angeles, California 90027
1 trial
University of California Los Angeles
Los Angeles, California 90095-3075
Conditions
Diseases this institution publishes on or runs trials for.
- Stroke398 works · 5 trials
- HIV367 works · 5 trials
- Obesity291 works · 4 trials
- Heart failure286 works · 4 trials
- Prostate cancer236 works · 25 trials
- Lung cancer218 works · 31 trials
- Alzheimer disease213 works · 9 trials
- Type 2 diabetes143 works · 6 trials
- Schizophrenia111 works · 10 trials
- Liver and biliary tract cancer103 works · 9 trials
- Chronic kidney disease102 works · 4 trials
- Epilepsy95 works · 6 trials
- Colorectal cancer94 works · 16 trials
- Ovarian cancer91 works · 11 trials
- Autism90 works · 5 trials
- Glioblastoma90 works · 12 trials
- Psoriasis89 works · 3 trials
- Melanoma85 works · 12 trials
- Coronary artery disease83 works · 5 trials
- Atrial fibrillation79 works · 2 trials
- Parkinson disease74 works · 11 trials
- Asthma74 works · 0 trials
- Depression63 works · 0 trials
- Deep vein thrombosis and pulmonary embolism62 works · 2 trials
- Atopic dermatitis (eczema)61 works · 5 trials
- COPD59 works · 4 trials
- Glaucoma58 works · 0 trials
- Macular degeneration58 works · 1 trial
- Congenital heart disease57 works · 5 trials
- Sarcoma55 works · 9 trials
Institution data: ROR 046rm7j60 (CC0-1.0)Updated 15 Nov 2026